POGWY yields 5.34% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, POGWY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of POGWY + PFE for your $10,000?
As of November 2, 2022, Polskie Górnictwo Naftowe i Gazownictwo S.A. was acquired by Polski Koncern Naftowy ORLEN Spólka Akcyjna. Polskie Górnictwo Naftowe i Gazownictwo S.A. explores for, produces, and sells natural gas and crude oil in Poland and internationally. The company operates in five segments: Exploration and Production, Trade and Storage, Distribution, Generation, and Other. The Exploration and Production segment explores for and produces natural gas and crude oil from deposits, including geological surveys, geophysical research, drilling, and development gas and oil fields, and production of hydrocarbons. The Trade and Storage segment trades in natural gas and electricity; and operates underground gas storage facilities. The Distribution segment is involved in the distribution of natural gas through distribution network to retail, industrial, and wholesale customers; and operation, maintenance, and expansion of gas distribution networks. The Generation segment generates and sells electricity and heat. The Other segment is involved in the engineering design and construction of structures; and provision of machinery and equipment for the extraction and energy sectors, as well as catering and hospitality, and insurance services. The company was founded in 1982 is headquartered in Warsaw, Poland.
Full POGWY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.